Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis

British Journal of Oral and Maxillofacial Surgery

Volumn 28, Issue 2, 1990, Pages 89-91

  Matejka, M ^a   Nell, A ^a   Kment, G ^a   Schein, A ^a   Leukauf, M ^a   Portedera, H ^a   Mailath, G ^c   Sinzinger, H ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^c Second Department Oto Laryngology University of Vienna ^*

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MAXILLOFACIAL DISORDER; MOUTH INFLAMMATION; MOUTH MUCOSA; RADIOISOTOPE THERAPY; TOPICAL DRUG ADMINISTRATION;

AGED; ANALYSIS OF VARIANCE; DINOPROSTONE; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGE; MOUTH MUCOSA; RADIOTHERAPY; STOMATITIS;

EID: 0025083178     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0266-4356(90)90128-8     Document Type: Article

References (12)

1. Opportunistic Gram-negative bacillary infections in leukaemia and manifestations during myelosupression
2. Stomatotoxic manifestations of cancer chemotherapy
3. Prostaglandin E2 for chronic leg ulcers
4. Topical prostaglandin E2 in the treatment of chronic ulcers—a pilot study
5. Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2. A method for its stable degradation product: 11-deoxy-13,14-dihydro 15-keto-11β16E-cycloprostaglandin E2
6. Prostaglandins and protection of gastroduodenal mucosa
7. Topical PGE2 enhances healing of chemotherapy associated in mucosal lesions
8. The effect of cytotoxic therapy on saliva and oral flora
9. Antibodies against hydration product of 15-keto-13,14-dihydro-prostaglandin E2
10. Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles
11. Prostaglandins in irradiation-induced mucositis